Qiagen, Natera Partner to Develop NGS Assays
For use on Qiagen’s next-generation sequencing system, the cell-free DNA assays will enable access to genetic testing, including prenatal screening, in hospitals and laboratories globally.
Read MorePosted by Elaine Sanchez Wilson | Apr 26, 2018 | Prenatal Testing, Software |
For use on Qiagen’s next-generation sequencing system, the cell-free DNA assays will enable access to genetic testing, including prenatal screening, in hospitals and laboratories globally.
Read MorePosted by Elaine Sanchez Wilson | Apr 23, 2018 | Clinical Chemistry |
PerkinElmer has announced a collaboration with Helix to develop and commercialize exome sequencing-based tests intended to enable consumers to make proactive health management decisions.
Read MorePosted by Elaine Sanchez Wilson | Apr 23, 2018 | Microbiology |
Together with the Unyvero LRT application cartridge, the sample-to-answer Unyvero system provides rapid infectious disease testing directly from aspirate samples in less than 5 hours.
Read MorePosted by Elaine Sanchez Wilson | Apr 19, 2018 | Disease States |
Progress and challenges are on the way to a blood-based assay for PD-L1.
Read MorePosted by Elaine Sanchez Wilson | Apr 12, 2018 | Prostate |
Updated guidelines include new language supporting the use of Prolaris, from Myriad Genetics, as standard of care in treatment decisionmaking for patients with low-risk and favorable-intermediate-risk prostate cancer.
Read More